EE84 A Reexamination of Drug Costs for Cetuximab and Panitumimab in Metastatic Colorectal Cancer: Assessing the Influence of Drug Vial Splitting

Abstract

Authors

S Puskuru B Rittenhouse JD Kallich T Eguale

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×